*February 2025* The lung cancer community has a dire need for more advocates in order for us (both survivors and caregivers) to have more voice and involvement in research projects, clinical trials, and government research funding. Before you make the deep dive into advocacy, here are some networks and recorded…

*May 2024* In part 1 of a 3-part Advocacy 101 series, the LUNGevity Action Network presents a conversation with longtime advocate and lung cancer survivor Jill Feldman. After a brief introduction to the different types of advocacy—self/patient, political, research/scientific, and media—Jill answers questions and shares just how important advocacy is…

*June 2024* Lung Cancer has taken yet another bright light from our world: a beautiful soul. But it can never take away Ivy's impact on countless lives, a testament to her strength and resilience that continues to inspire us all. Ivy was diagnosed with stage IV EGFR-positive lung cancer in…

*June 2024* This recorded zoom call features our co-founder Jill Feldman and leading advocate Dusty Donaldson. This is the project of an IASLC Patient Educational Award winner Yvonne Diaz, aimed at encouraging more advocacy efforts in lung cancer.  Jill and Dusty discuss everything from getting started to a range of…

*March 2024* Podcast Host:  Hildy Grossman with Jordan Rich, co-host Podcast Guests: Cheryl Davis, of Red Thred Solutions; Lauren Coye, Patient and Patient Advocate What often goes unheard in medical situations is the patient’s voice. Our guests have a lot to say about this matter. Cheryl Davis has extensive experience…

*March 2024* Sharing your stories and experiences as someone impacted by lung cancer can help create positive change. Whether you are a patient, survivor, caregiver, healthcare provider, family member, or friend, adding your voice as a lung cancer advocate can help humanize important issues and statistics for policymakers and decision-makers.…

*March 2024* The American Society of Clinical Oncology (ASCO) has announced Jill Feldman, as the recipient of the 2024 ASCO Patient Advocate Award. This award acknowledges Dr. Newman’s dedication and contributions to the field of global oncology. Jill Feldman, is a lung cancer patient and passionate advocate with a personal connection to the cause.…

*March 2024* For cancer patients, the harsh side effects of powerful drugs have long been the trade-off for living longer. Now, patients and doctors are questioning whether all that suffering is necessary. They’ve ignited a movement to radically change how new cancer drugs are tested, with the U.S. Food and…

Many of the things we take for granted as lung cancer patients are those people who have made a difference to our lives either by working for more research funding, making sure that clinical trial and lung caner guidelines as well as cancer care are more patient-centric. We benefit in many ways from…

*November 2023* Patients want improved efficacy, but not necessarily at the expense of their quality of life. Combination treatment comes with increased toxicities, which make maintaining a normal life more difficult. Even grade 1 side effects such as diarrhea or nausea can make it difficult to hold a job or…